AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)

Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous immune-mediated peripheral neuropathy with progressive or relapse-remitting course. Incidence of CIDP ranged between 1 and 8.9/100 000. Recently, most frequent therapies for CIDP treatment was glucocorticosteroids, intraveno...

Full description

Bibliographic Details
Main Authors: Roman A. Gapeshin, Evgeny R. Barantsevich, Dmitry I. Rudenko, Oksana V. Posokhina, Tima R. Stuchevskaya
Format: Article
Language:Russian
Published: Academician I.P. Pavlov First St. Petersburg State Medical University 2019-08-01
Series:Učenye Zapiski Sankt-Peterburgskogo Gosudarstvennogo Medicinskogo Universiteta im. Akad. I.P. Pavlova
Subjects:
Online Access:https://www.sci-notes.ru/jour/article/view/567
id doaj-43560cda30f24029ab4feb800128b50c
record_format Article
spelling doaj-43560cda30f24029ab4feb800128b50c2021-07-29T08:01:56ZrusAcademician I.P. Pavlov First St. Petersburg State Medical UniversityUčenye Zapiski Sankt-Peterburgskogo Gosudarstvennogo Medicinskogo Universiteta im. Akad. I.P. Pavlova1607-41812019-08-0126191910.24884/1607-4181-2019-26-1-9-19434AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)Roman A. Gapeshin0Evgeny R. Barantsevich1Dmitry I. Rudenko2Oksana V. Posokhina3Tima R. Stuchevskaya4Pavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversityPavlov UniversityChronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous immune-mediated peripheral neuropathy with progressive or relapse-remitting course. Incidence of CIDP ranged between 1 and 8.9/100 000. Recently, most frequent therapies for CIDP treatment was glucocorticosteroids, intravenous immunoglobulin and plasma exchange. In cases of ineffectiveness or lack of effectiveness, cytostatics, monoclonal antibodies and others could be used for CIDP treatment. In the article, authors presented an update data on the use of main methods for CIDP therapy, their mechanisms of action, indication for their use and advantages and disadvantages of each of them.https://www.sci-notes.ru/jour/article/view/567chronic inflammatory demyelinating polyneuropathyglucocorticosteroidsintravenous immunoglobulinplasma exchangetreatmentelectroneuromyographyautoimmune disease
collection DOAJ
language Russian
format Article
sources DOAJ
author Roman A. Gapeshin
Evgeny R. Barantsevich
Dmitry I. Rudenko
Oksana V. Posokhina
Tima R. Stuchevskaya
spellingShingle Roman A. Gapeshin
Evgeny R. Barantsevich
Dmitry I. Rudenko
Oksana V. Posokhina
Tima R. Stuchevskaya
AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
Učenye Zapiski Sankt-Peterburgskogo Gosudarstvennogo Medicinskogo Universiteta im. Akad. I.P. Pavlova
chronic inflammatory demyelinating polyneuropathy
glucocorticosteroids
intravenous immunoglobulin
plasma exchange
treatment
electroneuromyography
autoimmune disease
author_facet Roman A. Gapeshin
Evgeny R. Barantsevich
Dmitry I. Rudenko
Oksana V. Posokhina
Tima R. Stuchevskaya
author_sort Roman A. Gapeshin
title AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
title_short AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
title_full AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
title_fullStr AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
title_full_unstemmed AN UPDATE DATA ON THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (review of literature)
title_sort update data on the treatment of chronic inflammatory demyelinating polyneuropathy (review of literature)
publisher Academician I.P. Pavlov First St. Petersburg State Medical University
series Učenye Zapiski Sankt-Peterburgskogo Gosudarstvennogo Medicinskogo Universiteta im. Akad. I.P. Pavlova
issn 1607-4181
publishDate 2019-08-01
description Chronic inflammatory demyelinating polyneuropathy (CIDP) is a heterogeneous immune-mediated peripheral neuropathy with progressive or relapse-remitting course. Incidence of CIDP ranged between 1 and 8.9/100 000. Recently, most frequent therapies for CIDP treatment was glucocorticosteroids, intravenous immunoglobulin and plasma exchange. In cases of ineffectiveness or lack of effectiveness, cytostatics, monoclonal antibodies and others could be used for CIDP treatment. In the article, authors presented an update data on the use of main methods for CIDP therapy, their mechanisms of action, indication for their use and advantages and disadvantages of each of them.
topic chronic inflammatory demyelinating polyneuropathy
glucocorticosteroids
intravenous immunoglobulin
plasma exchange
treatment
electroneuromyography
autoimmune disease
url https://www.sci-notes.ru/jour/article/view/567
work_keys_str_mv AT romanagapeshin anupdatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT evgenyrbarantsevich anupdatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT dmitryirudenko anupdatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT oksanavposokhina anupdatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT timarstuchevskaya anupdatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT romanagapeshin updatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT evgenyrbarantsevich updatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT dmitryirudenko updatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT oksanavposokhina updatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
AT timarstuchevskaya updatedataonthetreatmentofchronicinflammatorydemyelinatingpolyneuropathyreviewofliterature
_version_ 1721258708885831680